Industry

The researchers find that the drug effects for reducing psychosis are small and that treatment failure and severe side effects are common.

Last week, well-known Stanford scientist John Ioannidis and his colleague Denes Szucs released a new analysis online. They examined research published in eighteen prominent...

A new study claims that quantitative research in psychology is “worryingly imprecise” and that generalizations may be flawed and misleading.

New study finds that antidepressants may negatively impact recovery after psychiatric hospitalization.

A new article documents the “flimsy evidence” behind the recent FDA approval of the party drug esketamine for the treatment of depression.

Prominent researchers conduct a review of antidepressant withdrawal incidence, duration, and severity. Results lead to call for new clinical guidelines.

Well known Stanford University researcher John Ioannidis published a new paper this week criticizing the use and production of systematic reviews and meta-analyses, often...

A massive number of meta-analyses of antidepressant clinical trials have financial conflicts of interest and are unduly influenced by pharmaceutical companies, according to a review to be published in an upcoming issue of the Journal of Clinical Epidemiology. Researchers also found that meta-analyses with industry ties almost never report any negative findings in their abstracts.

Members of the U.S. Food and Drug Administration’s Psychiatry Products division go on the defensive in a new article, responding to concerns about the agency’s approval of digital aripiprazole.

For CounterPunch, Martha Rosenberg and Ronnie Cummins comment on the announcement that Bayer has placed a bid to buy Monsanto. “Bayer and Monsanto both...

A closer look at a new study reporting that the supplement D-cycloserine improved anxiety when used with exposure therapy.

Although opioid addiction and overuse have garnered significant national attention, similar trends in benzodiazepine overprescription and overuse continue to go unnoticed.

Correcting unnecessary long-term antidepressant use is difficult and met with apprehension by providers and service-users.

-A psychiatrist asserts that psychiatrists and pharmaceutical companies never promoted the idea that serotonin deficiencies could cause depression, and suggests that no one at Mad in America has evidence that they did.

A review article and meta-analysis of 18 articles published in the journal of Psychological Medicine reported effects of vitamin and/or mineral supplements on psychiatric symptoms in people diagnosed with schizophrenia. The study provides evidence of the beneficial effects of taking certain vitamins and minerals for improving symptoms associated with schizophrenia.

A large review and meta-analysis of 167 studies across 60 years dissects placebo-controlled randomized controlled trials of antipsychotic drugs.

In a major study, published yesterday in JAMA Pediatrics, the use of SSRI antidepressants during pregnancy was found to increase the risk of autism spectrum disorder (ASD) by 87-percent. Previous studies reveal that more than 13-percent of women currently use SSRI antidepressants during pregnancy.

Researchers point to the risks of using antipsychotics with youth and caution against the practice.

Black patients are almost twice as likely as their white counterparts to be diagnosed with schizophrenia while whites are significantly more likely to receive a diagnosis of anxiety or depression, according to a recent study published in the journal Psychiatric Services. The researchers also found that the likelihood of receiving psychotherapy for any diagnosis (34%), regardless of race or ethnicity, was much lower than the likelihood of receiving a psychotropic medication (73%).

Yale's Program for Recovery and Community Health will publish in World Psychiatry's June issue a review the history of peer support, from its roots...

New review ties increased screen time to increasing anxiety and depression among young adults throughout the United States.

A new study, published this month in the Journal of Affective Disorders, investigated the effectiveness of weekly intravenous ketamine injections as a treatment for...

The death toll among Japanese citizens who have taken Johnson & Johnson's subsidiary Janssen's schizophrenia drug Xeplion has climbed to 21, from 17 on...

In a study released June 6, 2012 through the online journal Behavioral and Brain Functions, researchers from Japan acknowledge that "the results of association...

Researchers find that valproate decreases brain volume in a region associated with emotion processing across all participants.